0,896  0,003  Caspase 9 stimulant
0,865  0,009  Apoptosis agonist
0,824  0,012  Antiinflammatory
0,809  0,008  TNF expression inhibitor
0,807  0,009  Antineoplastic (breast cancer)
0,795  0,009  Antineoplastic (lung cancer)
0,781  0,014  Transcription factor NF kappa B inhibitor
0,767  0,007  Chemopreventive
0,762  0,003  UGT1A4 substrate
0,720  0,013  Antineoplastic (colorectal cancer)
0,717  0,011  Antileukemic
0,716  0,012  Antineoplastic (colon cancer)
0,706  0,009  Prostate cancer treatment
0,701  0,006  Antineoplastic (melanoma)
0,698  0,006  NOS2 expression inhibitor
0,700  0,009  Antineoplastic (ovarian cancer)
0,680  0,006  Hepatic disorders treatment
0,659  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,652  0,007  Nitric oxide antagonist
0,651  0,007  UGT1A6 substrate
0,640  0,010  UGT1A9 substrate
0,620  0,005  Antineoplastic (endocrine cancer)
0,623  0,012  Antineoplastic (cervical cancer)
0,621  0,009  Caspase 3 stimulant
0,621  0,010  Cytotoxic
0,613  0,003  UGT2B15 substrate
0,622  0,015  Antihypercholesterolemic
0,607  0,015  Chemoprotective
0,597  0,008  Antineoplastic (multiple myeloma)
0,600  0,019  Cholesterol antagonist
0,582  0,004  UGT2B4 substrate
0,587  0,012  AR expression inhibitor
0,576  0,010  Antineoplastic (glioma)
0,564  0,005  Hepatoprotectant
0,570  0,014  Antineoplastic (pancreatic cancer)
0,553  0,013  Antineoplastic (brain cancer)
0,542  0,016  Antioxidant
0,531  0,017  Proliferative diseases treatment
0,516  0,005  Interferon gamma antagonist
0,519  0,009  ICAM1 expression inhibitor
0,520  0,018  Apoptosis antagonist
0,522  0,021  Sensitization
0,509  0,013  Antineoplastic (glioblastoma multiforme)
0,500  0,005  UGT2B7 substrate
0,511  0,019  NOS3 expression inhibitor
0,519  0,028  Immunosuppressant
0,501  0,012  UDP-glucuronosyltransferase substrate
0,496  0,010  UGT1A1 substrate
0,500  0,015  Antipyretic
0,516  0,045  Antidiabetic
0,516  0,045  Cyclophilin D inhibitor
0,489  0,038  CYP2C9 substrate
0,472  0,025  Lipoprotein disorders treatment
0,462  0,018  Antineoplastic (lymphoma)
0,456  0,014  Antihypoxic
0,475  0,041  Antipruritic, allergic
0,447  0,016  Antineoplastic (liver cancer)
0,442  0,016  Antineoplastic (renal cancer)
0,472  0,046  CYP3A4 substrate
0,437  0,014  Antineoplastic (lymphocytic leukemia)
0,443  0,025  Antineoplastic (non-small cell lung cancer)
0,427  0,010  Melanin inhibitor
0,451  0,036  Bone diseases treatment
0,439  0,025  Cardiovascular analeptic
0,424  0,012  Contraceptive
0,448  0,036  5 Hydroxytryptamine release stimulant
0,414  0,004  Cholesterol synthesis inhibitor
0,421  0,013  Abortion inducer
0,414  0,013  Sodium/bile acid cotransporter inhibitor
0,451  0,056  Antibacterial
0,435  0,041  Antithrombotic
0,430  0,039  Respiratory analeptic
0,422  0,033  Antiosteoporotic
0,390  0,005  Antiinfertility, female
0,406  0,020  Vascular (periferal) disease treatment
0,393  0,008  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,419  0,034  Cardioprotectant
0,391  0,012  Platelet adhesion inhibitor
0,383  0,013  Antiviral (Influenza)
0,398  0,030  Antiprotozoal (Leishmania)
0,388  0,023  Antihypertriglyceridemic
0,368  0,003  UGT2B10 substrate
0,393  0,028  Tumour necrosis factor alpha release inhibitor
0,375  0,013  UGT1A3 substrate
0,370  0,009  Antiviral (Influenza A)
0,397  0,037  CTGF expression inhibitor
0,387  0,028  Hypolipemic
0,372  0,014  Prostatic (benign) hyperplasia treatment
0,361  0,006  UGT2B9 substrate
0,367  0,013  Prostate disorders treatment
0,370  0,018  Antiviral (HIV)
0,381  0,030  Cardiodepressant
0,360  0,011  Protein-tyrosine phosphatase inhibitor
0,379  0,033  Free radical scavenger
0,353  0,007  Antifungal enhancer
0,392  0,048  Aldehyde oxidase inhibitor
0,376  0,032  Hypoglycemic
0,348  0,004  Choleretic
0,351  0,009  Neurotrophic factor enhancer
0,368  0,028  Angiogenesis stimulant
0,341  0,008  Protein-tyrosine phosphatase 1B inhibitor
0,343  0,012  Protein kinase stimulant
0,374  0,045  CYP2C19 substrate
0,319  0,005  Contraceptive female
0,347  0,034  Transcription factor STAT3 inhibitor
0,371  0,058  Immunostimulant
0,326  0,015  Lipid peroxidase inhibitor
0,306  0,008  UGT2B1 substrate
0,314  0,019  Lipocortins synthesis antagonist
0,333  0,040  Transcription factor STAT inhibitor
0,324  0,032  Antineoplastic (sarcoma)
0,311  0,020  Antineoplastic (squamous cell carcinoma)
0,304  0,017  Monophenol monooxygenase inhibitor
0,326  0,041  Carcinogenic
0,329  0,050  Antidiabetic (type 2)
0,281  0,005  AMP-activated protein kinase stimulant
0,323  0,049  DNA damaging
0,331  0,058  Analeptic
0,282  0,011  LDLR expression enhancer
0,293  0,023  Antineoplastic (carcinoma)
0,314  0,043  Vasodilator
0,284  0,019  Liver fibrosis treatment
0,278  0,014  Antihyperlipoproteinemic
0,311  0,049  Cytostatic
0,339  0,078  Vasodilator, peripheral
0,282  0,022  Skin whitener
0,267  0,009  Farnesoid X receptor antagonist
0,286  0,029  Antimutagenic
0,279  0,026  Antiviral (Herpes)
0,270  0,018  Acute respiratory distress syndrome (ARDS) treatment
0,260  0,012  Antihemorrhagic
0,269  0,027  Antiacne
0,315  0,073  Antifungal
0,254  0,016  DNA polymerase I inhibitor
0,245  0,009  Androgen antagonist
0,244  0,010  Microtubule formation inhibitor
0,281  0,049  Antiulcerative
0,292  0,064  Teratogen
0,256  0,027  Hair growth stimulant
0,262  0,038  P-glycoprotein inhibitor
0,275  0,051  Antimitotic
0,223  0,003  UGT2B11 substrate
0,231  0,011  Arachidonic acid antagonist
0,250  0,032  Antihelmintic (Nematodes)
0,244  0,026  Phospholipase C inhibitor
0,237  0,021  Interleukin 1 antagonist
0,232  0,016  Antineoplastic antibiotic
0,249  0,035  Insulin sensitizer
0,218  0,008  Aromatase inhibitor
0,236  0,026  Interleukin 6 antagonist
0,288  0,082  Interleukin 2 agonist
0,250  0,044  Antihelmintic
0,210  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,277  0,071  Renal disease treatment
0,229  0,024  Insulin secretagoues
0,220  0,023  Antiviral (Hepatitis B)
0,214  0,018  Expectorant
0,198  0,004  Bile acid receptor antagonist
0,262  0,069  Embryotoxic
0,331  0,140  Alzheimer's disease treatment
0,229  0,041  Antiviral (Hepatitis)
0,196  0,009  Transcription factor NF kappa B stimulant
0,214  0,030  Antidiarrheal
0,201  0,018  SULT1A1 substrate
0,224  0,041  Diabetic nephropathy treatment
0,195  0,016  Adenylate cyclase stimulant
0,196  0,017  Sulfotransferase substrate
0,242  0,064  Antiparasitic
0,195  0,018  Beta amyloid protein antagonist
0,236  0,059  RNA-directed DNA polymerase inhibitor
0,221  0,048  Antipruritic, non-allergic
0,282  0,111  Calcium channel activator
0,257  0,088  Radioprotector
0,176  0,008  Anabolic
0,171  0,006  Glutamate release inhibitor
0,187  0,024  Cyclooxygenase 3 inhibitor
0,200  0,039  Antirickettsial
0,188  0,029  Glutathione S-transferase substrate
0,169  0,012  Inducible nitric-oxide synthase inhibitor
0,165  0,010  Antiviral (SARS coronavirus)
0,165  0,010  Antiviral (Coronavirus)
0,218  0,063  Wound healing agent
0,233  0,079  Antiamyloidogenic
0,240  0,091  Gastrin inhibitor
0,225  0,077  Antihypotensive
0,153  0,005  Na+ K+ transporting ATPase inhibitor
0,168  0,021  HDL-cholesterol increasing
0,192  0,047  Antiviral (Hepatitis C)
0,190  0,048  Amylase inhibitor
0,214  0,074  Antineoplastic enhancer
0,141  0,003  Heme oxygenase stimulant
0,183  0,046  Anesthetic
0,151  0,014  Paget's disease treatment
0,181  0,045  Genotoxic
0,276  0,141  Atherosclerosis treatment
0,244  0,109  CYP2D6 substrate
0,150  0,017  ABCA1 expression enhancer
0,204  0,072  Anesthetic general
0,140  0,008  Androgen agonist
0,209  0,078  VCAM1 expression inhibitor
0,186  0,055  Toxic, respiratory center
0,184  0,055  Antineoplastic (bone cancer)
0,152  0,023  Estrogen antagonist
0,188  0,062  Antineoplastic (gastric cancer)
0,135  0,012  Glycine receptor antagonist
0,141  0,019  SULT1E1 substrate
0,153  0,030  Anticataract
0,130  0,009  Anticholelithogenic
0,241  0,127  Antineoplastic (osteosarcoma)
0,117  0,005  RNA-directed RNA polymerase stimulant
0,147  0,036  Endometrios treatment
0,124  0,013  Estrogen agonist
0,114  0,006  Potassium channel Kv1.3 blocker
0,147  0,041  Vanilloid 1 agonist
0,115  0,009  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,207  0,103  Myocardial infarction treatment
0,147  0,044  Growth stimulant
0,157  0,055  Tubulin antagonist
0,216  0,113  Antineoplastic (bladder cancer)
0,130  0,032  Prolactin inhibitor
0,147  0,051  Ca2+-transporting ATPase inhibitor
0,117  0,023  Contraceptive male
0,200  0,107  Antidiabetic symptomatic
0,122  0,030  Estrogen receptor beta antagonist
0,111  0,019  HIV-1 integrase (Strand Transfer) inhibitor
0,109  0,019  SULT1A2 substrate
0,095  0,006  Acetyl-CoA transferase 2 inhibitor
0,107  0,017  Glycine receptor agonist
0,104  0,017  Postmenopausal disorders treatment
0,140  0,054  Topoisomerase II inhibitor
0,137  0,054  Alkylator
0,105  0,024  Estrogen receptor alpha antagonist
0,151  0,072  NOS3 expression enhancer
0,111  0,033  Ornithine decarboxylase inhibitor
0,161  0,083  ATPase inhibitor
0,100  0,022  Hyperparathyroidism treatment
0,081  0,005  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,213  0,140  Metabolic disease treatment
0,212  0,139  CYP1A2 substrate
0,086  0,014  Estrogen receptor beta agonist
0,082  0,012  Postcoital contraceptive
0,108  0,040  Actinic keratosis treatment
0,081  0,013  Lipocortins synthesis agonist
0,121  0,054  Mucolytic
0,121  0,055  Topoisomerase I inhibitor
0,070  0,004  Cholesterol ester transfer protein antagonist
0,089  0,026  Beta tubulin antagonist
0,129  0,066  Antiseptic
0,101  0,039  Topoisomerase II alpha inhibitor
0,139  0,077  Pregnane X receptor agonist
0,135  0,073  Psychosexual dysfunction treatment
0,083  0,022  SULT2A1 substrate
0,095  0,034  Keratolytic
0,107  0,046  Lanosterol 14 alpha demethylase inhibitor
0,067  0,008  Farnesoid X receptor agonist
0,063  0,005  Tubulin agonist
0,076  0,018  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,121  0,064  Alcohol dehydrogenase substrate
0,090  0,034  Narcotic antagonist
0,215  0,162  GST M1-1 substrate
0,088  0,036  Histone deacetylase stimulant
0,088  0,036  Histone deacetylase SIRT1 stimulant
0,157  0,105  Septic shock treatment
0,058  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,169  0,118  VEGF expression inhibitor
0,059  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,076  0,026  Antimycoplasmal
0,184  0,136  Interleukin agonist
0,141  0,092  Sigma receptor agonist
0,156  0,108  Non-steroidal antiinflammatory agent
0,101  0,055  DNA directed RNA polymerase inhibitor
0,133  0,086  SULT1A3 substrate
0,104  0,058  Dementia treatment
0,070  0,024  Acetyl-CoA transferase inhibitor
0,119  0,075  Coagulant
0,057  0,013  Parathyroid hormone antagonist
0,100  0,056  Vascular dementia treatment
0,059  0,016  Microtubule stabilization
0,191  0,149  Lipoxygenase inhibitor
0,078  0,037  Potassium channel large-conductance Ca-activated activator
0,082  0,041  CDC25A inhibitor
0,066  0,026  Alpha tubulin antagonist
0,119  0,079  Acetylcholinesterase inhibitor
0,054  0,017  5-Alpha-reductase inhibitor
0,120  0,086  Cocaine dependence treatment
0,039  0,005  Hedgehog signaling activator
0,086  0,053  3C-Like protease (SARS coronavirus) inhibitor
0,085  0,052  Estrogen-related receptor beta agonist
0,222  0,190  15-Lipoxygenase inhibitor
0,095  0,062  Posttraumatic stress disorder treatment
0,047  0,016  Glucocorticoid antagonist
0,036  0,006  Dopamine D1 agonist
0,060  0,031  Pregnane X receptor antagonist
0,087  0,060  Tocolytic
0,036  0,009  Estrone sulfatase inhibitor
0,045  0,019  Estrogen receptor alpha agonist
0,040  0,015  HMG CoA reductase inhibitor
0,091  0,066  Antiviral (Rhinovirus)
0,104  0,080  Antitussive
0,026  0,004  Telomerase stimulant
0,045  0,023  Hypogonadism treatment
0,032  0,011  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,053  0,033  Anesthetic inhalation
0,177  0,158  DNA synthesis inhibitor
0,142  0,124  Interleukin antagonist
0,042  0,024  Cholesterol absorption inhibitor
0,048  0,031  Phosphorylase inhibitor
0,042  0,027  Liver X receptor alpha agonist
0,079  0,064  Thioredoxin reductase inhibitor
0,098  0,083  Interleukin 1b antagonist
0,024  0,011  Corticosteroid-like
0,059  0,048  HIV-1 integrase (3'-Processing) inhibitor
0,121  0,110  CC chemokine 6 receptor antagonist
0,017  0,007  Antibiotic Tetracycline-like
0,023  0,013  Vitamin D receptor antagonist
0,087  0,078  Protease inhibitor
0,066  0,058  Lipase inhibitor
0,065  0,057  Andropause treatment
0,054  0,047  Botulinum neurotoxin type A inhibitor
0,020  0,013  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,043  0,037  Adenylate cyclase 1 inhibitor
0,066  0,061  Antibiotic
0,034  0,031  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,079  0,076  Potassium channel (Ca-activated) activator
0,152  0,149  Cyclic AMP phosphodiesterase inhibitor
0,057  0,054  Nitric oxide donor
0,120  0,117  Phospholipase A2 inhibitor
0,059  0,058  Prolactin release inhibitor

